Last-Chance drug offered for debilitating stomach paralysis
NCT ID NCT04996134
Summary
This FDA program provided domperidone to patients with severe gastroparesis and other stomach disorders who didn't respond to standard treatments. The medication helps move food through the digestive system to relieve symptoms like nausea and vomiting. The program was specifically for patients age 12 and older who had exhausted other options, with careful screening for heart risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROPARESIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aurora BayCare Medical Center
Green Bay, Wisconsin, 54311, United States
Conditions
Explore the condition pages connected to this study.